UNSPSC 51385600: Nonsteroidal anti inflammatory salicylates

Nonsteroidal anti inflammatory drugs made of the salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.

UNSPSC 51385600 Nonsteroidal anti-inflammatory salicylates is a Class code, but the recent state and local opportunities tagged under it do not reflect its nominal scope. The three recent solicitations posted between January and June 2026 address naloxone and drug deactivation systems, therapeutic pharmacy initiatives, and generic multi-source pharmaceuticals and over-the-counter products — none of which are salicylate-class medications. The mismatch suggests either inconsistent taxonomy application in state and local procurement databases or a data-tagging error at the source. The code shows little relevant recent activity aligned with its stated pharmaceutical class.

The issuing bodies span state health agencies and cooperative purchasing vehicles: Seminole County, Florida (an IFB for naloxone and drug deactivation systems with quarterly deliveries); the Texas Health and Human Services Commission (an RFI exploring direct-to-manufacturer prescription relationships); and the Minnesota Multistate Cooperative Purchasing Alliance administering an RFP for generic pharmaceuticals and OTC products across multiple state and local members, including Oregon, with responses due March 26, 2026. Geographic activity clusters in Florida, Texas, and the Upper Midwest, though the MMCAP cooperative spans broader membership. Without properly classified salicylate-specific opportunities, the code does not support a meaningful market characterization or pursuit recommendation at this time.